메뉴 건너뛰기




Volumn 23, Issue 11, 2016, Pages 3736-3743

Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; KRAS PROTEIN, HUMAN; PROTEIN P21;

EID: 84976340247     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-016-5361-6     Document Type: Article
Times cited : (50)

References (33)
  • 2
    • 77952300630 scopus 로고    scopus 로고
    • Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution
    • House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744-52–752-45.
    • (2010) J Am Coll Surg , vol.210 , pp. 744-52-752-45
    • House, M.G.1    Ito, H.2    Gonen, M.3
  • 3
    • 68949094312 scopus 로고    scopus 로고
    • Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
    • PID: 19470929
    • Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677–83.
    • (2009) J Clin Oncol , vol.27 , pp. 3677-3683
    • Kopetz, S.1    Chang, G.J.2    Overman, M.J.3
  • 4
    • 84883680951 scopus 로고    scopus 로고
    • Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer
    • COI: 1:CAS:528:DC%2BC3sXhsFGktr3L, PID: 24024839
    • Douillard JY, Oliner KS, Siena S, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369:1023–34.
    • (2013) N Engl J Med , vol.369 , pp. 1023-1034
    • Douillard, J.Y.1    Oliner, K.S.2    Siena, S.3
  • 5
    • 84937143954 scopus 로고    scopus 로고
    • Metastatic colorectal cancer: current state and future directions
    • COI: 1:CAS:528:DC%2BC2MXht1eisb3L, PID: 25918280
    • Fakih MG. Metastatic colorectal cancer: current state and future directions. J Clin Oncol. 2015;33:1809–24.
    • (2015) J Clin Oncol , vol.33 , pp. 1809-1824
    • Fakih, M.G.1
  • 6
    • 68849110472 scopus 로고    scopus 로고
    • Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer
    • COI: 1:CAS:528:DC%2BD1MXht1Wns7vN, PID: 19474002
    • Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer. Gut. 2009;58:1234–41.
    • (2009) Gut , vol.58 , pp. 1234-1241
    • Seth, R.1    Crook, S.2    Ibrahem, S.3    Fadhil, W.4    Jackson, D.5    Ilyas, M.6
  • 7
    • 84939251514 scopus 로고    scopus 로고
    • Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
    • COI: 1:CAS:528:DC%2BC2MXhtlWiu7zJ, PID: 26206254
    • Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg. 2015;102:1175–83.
    • (2015) Br J Surg , vol.102 , pp. 1175-1183
    • Brudvik, K.W.1    Kopetz, S.E.2    Li, L.3    Conrad, C.4    Aloia, T.A.5    Vauthey, J.N.6
  • 8
    • 84918824615 scopus 로고    scopus 로고
    • KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases
    • COI: 1:CAS:528:DC%2BC2cXitVaqsLvJ, PID: 25155157
    • Kemeny NE, Chou JF, Capanu M, et al. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Cancer. 2014;120:3965–71.
    • (2014) Cancer , vol.120 , pp. 3965-3971
    • Kemeny, N.E.1    Chou, J.F.2    Capanu, M.3
  • 9
    • 84947127636 scopus 로고    scopus 로고
    • Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases
    • PID: 26077912
    • Margonis GA, Spolverato G, Kim Y, Karagkounis G, Choti MA, Pawlik TM. Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2015;22:4158–65.
    • (2015) Ann Surg Oncol , vol.22 , pp. 4158-4165
    • Margonis, G.A.1    Spolverato, G.2    Kim, Y.3    Karagkounis, G.4    Choti, M.A.5    Pawlik, T.M.6
  • 10
    • 84884493477 scopus 로고    scopus 로고
    • RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases
    • PID: 24018645
    • Vauthey JN, Zimmitti G, Kopetz SE, et al. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013;258:619–26.
    • (2013) Ann Surg , vol.258 , pp. 619-626
    • Vauthey, J.N.1    Zimmitti, G.2    Kopetz, S.E.3
  • 11
    • 0035098522 scopus 로고    scopus 로고
    • Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases
    • COI: 1:STN:280:DC%2BD3M7osFWksA%3D%3D, PID: 11237496
    • Petrowsky H, Sturm I, Graubitz O, et al. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. Eur J Surg Oncol. 2001;27:80–7.
    • (2001) Eur J Surg Oncol , vol.27 , pp. 80-87
    • Petrowsky, H.1    Sturm, I.2    Graubitz, O.3
  • 12
    • 84870670197 scopus 로고    scopus 로고
    • Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma
    • COI: 1:CAS:528:DC%2BC38XhslKrur%2FN, PID: 22674181
    • Rose JS, Serna DS, Martin LK, et al. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma. Cancer. 2012;118:6243–52.
    • (2012) Cancer , vol.118 , pp. 6243-6252
    • Rose, J.S.1    Serna, D.S.2    Martin, L.K.3
  • 13
    • 84863722109 scopus 로고    scopus 로고
    • BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy
    • COI: 1:CAS:528:DC%2BC38XpvVehsrk%3D, PID: 22331825
    • Teng HW, Huang YC, Lin JK, et al. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol. 2012;106:123–9.
    • (2012) J Surg Oncol , vol.106 , pp. 123-129
    • Teng, H.W.1    Huang, Y.C.2    Lin, J.K.3
  • 14
    • 0033788456 scopus 로고    scopus 로고
    • Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes’ C colon cancer
    • COI: 1:CAS:528:DC%2BD3cXotVOhtLw%3D, PID: 11051374
    • Bleeker WA, Hayes VM, Karrenbeld A, et al. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes’ C colon cancer. Am J Gastroenterol. 2000;95:2953–7.
    • (2000) Am J Gastroenterol , vol.95 , pp. 2953-2957
    • Bleeker, W.A.1    Hayes, V.M.2    Karrenbeld, A.3
  • 15
    • 84930804509 scopus 로고    scopus 로고
    • Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
    • COI: 1:STN:280:DC%2BC2MfksVGhug%3D%3D, PID: 25979833
    • Brule SY, Jonker DJ, Karapetis CS, et al. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. Eur J Cancer. 2015;51:1405–14.
    • (2015) Eur J Cancer , vol.51 , pp. 1405-1414
    • Brule, S.Y.1    Jonker, D.J.2    Karapetis, C.S.3
  • 16
    • 0025048761 scopus 로고
    • Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location
    • COI: 1:STN:280:DyaK3M%2Flt1Olug%3D%3D, PID: 2240880
    • Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113:779–88.
    • (1990) Ann Intern Med , vol.113 , pp. 779-788
    • Bufill, J.A.1
  • 17
    • 84922887961 scopus 로고    scopus 로고
    • Is right-sided colon cancer different to left-sided colorectal cancer? A systematic review
    • COI: 1:STN:280:DC%2BC2MzksVCisg%3D%3D, PID: 25468456
    • Lee GH, Malietzis G, Askari A, Bernardo D, Al-Hassi HO, Clark SK. Is right-sided colon cancer different to left-sided colorectal cancer? A systematic review. Eur J Surg Oncol. 2015;41:300–8.
    • (2015) Eur J Surg Oncol , vol.41 , pp. 300-308
    • Lee, G.H.1    Malietzis, G.2    Askari, A.3    Bernardo, D.4    Al-Hassi, H.O.5    Clark, S.K.6
  • 18
    • 40349100700 scopus 로고    scopus 로고
    • Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology
    • PID: 17532785
    • Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23:418–23.
    • (2008) J Gastroenterol Hepatol , vol.23 , pp. 418-423
    • Nawa, T.1    Kato, J.2    Kawamoto, H.3
  • 19
    • 84955572772 scopus 로고    scopus 로고
    • Right sided colon cancer as a distinct histopathological subtype with reduced prognosis
    • PID: 26824772
    • Nitsche U, Stogbauer F, Spath C, et al. Right sided colon cancer as a distinct histopathological subtype with reduced prognosis. Dig Surg. 2016;33:157–63.
    • (2016) Dig Surg , vol.33 , pp. 157-163
    • Nitsche, U.1    Stogbauer, F.2    Spath, C.3
  • 20
    • 84922536963 scopus 로고    scopus 로고
    • Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
    • COI: 1:STN:280:DC%2BC2cbltleksg%3D%3D, PID: 25057166
    • Missiaglia E, Jacobs B, D’Ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014;25:1995–2001.
    • (2014) Ann Oncol , vol.25 , pp. 1995-2001
    • Missiaglia, E.1    Jacobs, B.2    D’Ario, G.3
  • 22
    • 84908339502 scopus 로고    scopus 로고
    • Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
    • von Einem JC, Heinemann V, von Weikersthal LF, et al. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. J Cancer Res Clin Oncol. 2014;140:1607–14.
    • (2014) J Cancer Res Clin Oncol , vol.140 , pp. 1607-1614
    • von Einem, J.C.1    Heinemann, V.2    von Weikersthal, L.F.3
  • 23
    • 84884666514 scopus 로고    scopus 로고
    • Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
    • PID: 24073892
    • Popovici V, Budinska E, Bosman FT, Tejpar S, Roth AD, Delorenzi M. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer. BMC Cancer. 2013;13:439.
    • (2013) BMC Cancer , vol.13 , pp. 439
    • Popovici, V.1    Budinska, E.2    Bosman, F.T.3    Tejpar, S.4    Roth, A.D.5    Delorenzi, M.6
  • 24
    • 84930811951 scopus 로고    scopus 로고
    • Different treatment strategies and molecular features between right-sided and left-sided colon cancers
    • COI: 1:CAS:528:DC%2BC2MXhs1SgurvL, PID: 26074686
    • Shen H, Yang J, Huang Q, et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015;21:6470–8.
    • (2015) World J Gastroenterol , vol.21 , pp. 6470-6478
    • Shen, H.1    Yang, J.2    Huang, Q.3
  • 25
    • 84879685038 scopus 로고    scopus 로고
    • Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability
    • PID: 23010994
    • Umeda Y, Nagasaka T, Mori Y, et al. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. J Hepatobiliary Pancreat Sci. 2013;20:223–33.
    • (2013) J Hepatobiliary Pancreat Sci , vol.20 , pp. 223-233
    • Umeda, Y.1    Nagasaka, T.2    Mori, Y.3
  • 26
    • 63849088630 scopus 로고    scopus 로고
    • Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
    • PID: 19339720
    • Van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360:1408–17.
    • (2009) N Engl J Med , vol.360 , pp. 1408-1417
    • Van Cutsem, E.1    Kohne, C.H.2    Hitre, E.3
  • 27
    • 79956298812 scopus 로고    scopus 로고
    • Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status
    • PID: 21502544
    • Van Cutsem E, Kohne CH, Lang I, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011;29:2011–9.
    • (2011) J Clin Oncol , vol.29 , pp. 2011-2019
    • Van Cutsem, E.1    Kohne, C.H.2    Lang, I.3
  • 28
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases
    • COI: 1:STN:280:DyaK1MvitFahsw%3D%3D, PID: 10493478
    • Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18.
    • (1999) Ann Surg , vol.230 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3    Brennan, M.F.4    Blumgart, L.H.5
  • 29
    • 84937816541 scopus 로고    scopus 로고
    • Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy
    • COI: 1:CAS:528:DC%2BC2cXitFKltbbM, PID: 25532759
    • Maus MK, Hanna DL, Stephens CL, et al. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Pharmacogenomics J. 2015;15:354–62.
    • (2015) Pharmacogenomics J , vol.15 , pp. 354-362
    • Maus, M.K.1    Hanna, D.L.2    Stephens, C.L.3
  • 30
    • 0036242782 scopus 로고    scopus 로고
    • CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
    • COI: 1:CAS:528:DC%2BD38Xkt1Cru7s%3D, PID: 11984524
    • Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 2002;122:1376–87.
    • (2002) Gastroenterology. , vol.122 , pp. 1376-1387
    • Hawkins, N.1    Norrie, M.2    Cheong, K.3
  • 31
    • 0036895068 scopus 로고    scopus 로고
    • Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
    • PID: 12427779
    • van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut. 2002;51:797–802.
    • (2002) Gut. , vol.51 , pp. 797-802
    • van Rijnsoever, M.1    Grieu, F.2    Elsaleh, H.3    Joseph, D.4    Iacopetta, B.5
  • 32
    • 16644376564 scopus 로고    scopus 로고
    • Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases
    • PID: 15525826
    • Haddad R, Ogilvie RT, Croitoru M, et al. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases. Ann Surg Oncol. 2004;11:977–82.
    • (2004) Ann Surg Oncol. , vol.11 , pp. 977-982
    • Haddad, R.1    Ogilvie, R.T.2    Croitoru, M.3
  • 33
    • 58749102767 scopus 로고    scopus 로고
    • Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
    • COI: 1:CAS:528:DC%2BD1MXpsVSrsQ%3D%3D, PID: 19165197
    • Koopman M, Kortman GA, Mekenkamp L, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100:266–73.
    • (2009) Br J Cancer. , vol.100 , pp. 266-273
    • Koopman, M.1    Kortman, G.A.2    Mekenkamp, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.